Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)

CUSIP: 92337R101

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-1,748,286
Put/Call ratio
8.3%
SEC-reported price per share
$40.23
Number of holders
227
Value change
-$101,315,946
Number of buys
133
Open additional details 1 more signal available
Number of sells
93
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,325,000

Security key

92337R101

Report period

Q1 2026

Institutions

227

Top holders

10

Ownership snapshot

Top reported holders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
15/15
Latest evidence
04 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 8.9% 13D/G row: Avoro Capital Advisors LLC Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 8.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership Top 5
Avoro Capital Advisors LLC 8.9%
PRICE T ROWE ASSOCIATES INC /MD/ 7.7%
Deep Track Capital, LP 5.5%
Kynam Capital Management, LP 5.4%
James E. Flynn 5.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Avoro Capital Advisors LLC
13F 13D/G
Company
8.9%
from 13D/G
$298,213,288
5,888,888 shares
31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
7.7%
$276,595,072
5,461,988 shares
+$90,918,550 31 Dec 2025
Deep Track Capital, LP
13D/G 13F
Company
5.5%
$176,892,640
3,921,362 shares
$0 04 Mar 2026
Kynam Capital Management, LP
13F 13D/G
Company
5.4%
from 13D/G
$173,849,703
3,433,051 shares
31 Dec 2025
James E. Flynn
13D/G
Deerfield Mgmt, L.P.
5.2%
$75,299,151
3,348,117 shares
$0 06 Jun 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
5%
from 13D/G
$180,805,107
3,570,401 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
227
Shares
72,234,409
Rows available
227
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
214
Q1 2026 holders
227
Holder diff
13
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .